Axsome Therapeutics Inc.
AXSM
|
|
| |
|
| Trading Volume | 20,754 |
|
|
97.64 - 57.42 |
| Market Cap Full | $ 4.2B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 2.1% | 0.2% | -20% | 9.6% |
| Q2 | - | 4% | 16.5% | -7.5% |
| Q3 | - | 2.1% | -2.7% | 16.5% |
| Q4 | - | -7.1% | 19.1% | 72.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 13.1 | -9.6 | -2 | -14.9 | 8.1 | 9.1 | 9 | 2.1 | - | - | - | -14.5 |
| 2023 | |||||||||||
| -2.8 | -9.1 | -9.6 | 16 | 3.2 | -2.6 | 9.2 | 3 | -13.5 | -10.9 | 8.3 | 18 |
| 2022 | |||||||||||
| -27.4 | 2 | 47.9 | -23.2 | -21.4 | 53.2 | 0.8 | 65.3 | -30.1 | 1.2 | 60.1 | 6.7 |
| 2021 | |||||||||||
| -16.4 | -1.1 | -15.9 | 10.2 | -2.7 | 11.1 | -26.2 | -48.4 | 28.4 | 16.8 | -10.6 | 9.7 |
| 2020 | |||||||||||
| -18.6 | -10.2 | -24.7 | 61.5 | -19 | 6.9 | -13.3 | 3.3 | -2.5 | -7.7 | 9.3 | 12.3 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.3 | -1 | -0.8 | -0.9 |
| Q2 | -1.5 | -1.1 | -0.9 | -0.5 |
| Q3 | -1.3 | -1.1 | -0.9 | -0.6 |
| Q4 | 0 | -1.4 | -0.9 | -0.8 |
| A | -3.12 | -4.6 | -3.5 | -2.8 |